Targeting the PD-1/PD-L1 Axis in Human Vitiligo

被引:19
作者
Willemsen, Marcella [1 ,2 ]
Melief, Cornelis J. M. [3 ]
Bekkenk, Marcel W. [1 ,2 ]
Luiten, Rosalie M. [1 ,2 ]
机构
[1] Univ Amsterdam, Amsterdam Univ Med Ctr, Canc Ctr Amsterdam,Dept Dermatol, Amsterdam Infect & Immun Inst,Locat AMC, Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam Univ Med Ctr, Canc Ctr Amsterdam,Netherlands Inst Pigment Disor, Amsterdam Infect & Immun Inst,Locat AMC, Amsterdam, Netherlands
[3] ISA Pharmaceut, Leiden, Netherlands
关键词
vitiligo; programmed cell death 1 receptor; B7-H1; antigen; immune tolerance; autoimmunity; NONMELANOMA SKIN-CANCER; REGULATORY T-CELLS; STAGE-III; MELANOMA; AUTOIMMUNITY; PD-L1; EXPRESSION; NIVOLUMAB; RESPONSES; BLOCKADE;
D O I
10.3389/fimmu.2020.579022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoreactive CD8(+) T cells play a pivotal role in melanocyte destruction in autoimmune vitiligo. Immunotherapy for melanoma often leads to autoimmune side-effects, among which vitiligo-like depigmentation, indicating that targeting immune checkpoints can break peripheral tolerance against self-antigens in the skin. Therapeutically enhancing immune checkpoint signaling by immune cells or skin cells, making self-reactive T cells anergic, seems a promising therapeutic option for vitiligo. Here, we review the current knowledge on the PD-1/PD-L1 pathway in vitiligo as new therapeutic target for vitiligo therapy.
引用
收藏
页数:7
相关论文
共 64 条
[1]   Expression of immune checkpoints in active nonsegmental vitiligo: a pilot study [J].
Awad, Sherif S. ;
Touni, Ahmed A. ;
Gabril, Manal Y. .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (08) :982-988
[2]   Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor [J].
Belum, V. R. ;
Benhuri, B. ;
Postow, M. A. ;
Hellmann, M. D. ;
Lesokhin, A. M. ;
Segal, N. H. ;
Motzer, R. J. ;
Wu, S. ;
Busam, K. J. ;
Wolchok, J. D. ;
Lacouture, M. E. .
EUROPEAN JOURNAL OF CANCER, 2016, 60 :12-25
[3]   Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo [J].
Ben Ahmed, M. ;
Zaraa, I. ;
Rekik, R. ;
Elbeldi-Ferchiou, A. ;
Kourda, N. ;
Hmida, N. Belhadj ;
Abdeladhim, M. ;
Karoui, O. ;
Ben Osman, A. ;
Mokni, M. ;
Louzir, H. .
PIGMENT CELL & MELANOMA RESEARCH, 2012, 25 (01) :99-109
[4]   Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro [J].
Blank, C ;
Kuball, J ;
Voelkl, S ;
Wiendl, H ;
Becker, B ;
Walter, B ;
Majdic, O ;
Gajewski, TF ;
Theobald, M ;
Andreesen, R ;
Mackensen, A .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (02) :317-327
[5]   Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma [J].
Boasberg, Peter D. ;
Hoon, Dave S. B. ;
Piro, Lawrence D. ;
Martin, Maureen A. ;
Fujimoto, Akhide ;
Kristedja, Timothy S. ;
Bhachu, Sandeep ;
Ye, Xing ;
Deck, Regina R. ;
O'Day, Steven J. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (12) :2658-2663
[6]   Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3 [J].
Boniface, Katia ;
Jacquemin, Clement ;
Darrigade, Anne-Sophie ;
Dessarthe, Benoit ;
Martins, Christina ;
Boukhedouni, Nesrine ;
Vernisse, Charlotte ;
Grasseau, Alexis ;
Thiolat, Denis ;
Rambert, Jerome ;
Lucchese, Fabienne ;
Bertolotti, Antoine ;
Ezzedine, Khaled ;
Taieb, Alain ;
Seneschal, Julien .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (02) :355-364
[7]   A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo [J].
Cantón, I ;
Akhtar, S ;
Gavalas, NG ;
Gawkrodger, DJ ;
Blomhoff, A ;
Watson, PF ;
Weetman, AP ;
Kemp, EH .
GENES AND IMMUNITY, 2005, 6 (07) :584-587
[8]   Targeting Costimulatory Molecules to Improve Antitumor Immunity [J].
Capece, Daria ;
Verzella, Daniela ;
Fischietti, Mariafausta ;
Zazzeroni, Francesca ;
Alesse, Edoardo .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
[9]   CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin [J].
Cheuk, Stanley ;
Schlums, Heinrich ;
Serezal, Irene Gallais ;
Martini, Elisa ;
Chiang, Samuel C. ;
Marquardt, Nicole ;
Gibbs, Anna ;
Detlofsson, Ebba ;
Introini, Andrea ;
Forkel, Marianne ;
Hoog, Charlotte ;
Tjernlund, Annelie ;
Michaelsson, Jakob ;
Folkersen, Lasse ;
Mjosberg, Jenny ;
Blomqvist, Lennart ;
Ehrstrom, Marcus ;
Stahle, Mona ;
Bryceson, Yenan T. ;
Eidsmo, Liv .
IMMUNITY, 2017, 46 (02) :287-300
[10]   Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice [J].
Ding, HL ;
Wu, XF ;
Wu, J ;
Yagita, H ;
He, YN ;
Zhang, HG ;
Ren, HW ;
Gao, WD .
CLINICAL IMMUNOLOGY, 2006, 118 (2-3) :258-267